Palo Alto Investors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.2M | Sell |
840,470
-150,737
| -15% | -$8.29M | 9.83% | 3 |
|
|
2025
Q1 | $70.1M | Sell |
991,207
-76,059
| -7% | -$5.38M | 13.34% | 2 |
|
|
2024
Q4 | $70.2M | Sell |
1,067,266
-22,790
| -2% | -$1.5M | 10.87% | 3 |
|
|
2024
Q3 | $76.6M | Sell |
1,090,056
-40,111
| -4% | -$2.82M | 9.95% | 3 |
|
|
2024
Q2 | $93M | Sell |
1,130,167
-4,402
| -0.4% | -$362K | 10.78% | 2 |
|
|
2024
Q1 | $99.1M | Sell |
1,134,569
-366,180
| -24% | -$32M | 11.18% | 3 |
|
|
2023
Q4 | $145M | Sell |
1,500,749
-330,286
| -18% | -$31.8M | 13.04% | 3 |
|
|
2023
Q3 | $162M | Hold |
1,831,035
| – | – | 15.33% | 1 |
|
|
2023
Q2 | $159M | Hold |
1,831,035
| – | – | 12.82% | 1 |
|
|
2023
Q1 | $178M | Sell |
1,831,035
-54,776
| -3% | -$5.33M | 14.75% | 1 |
|
|
2022
Q4 | $195M | Sell |
1,885,811
-90,454
| -5% | -$9.36M | 16.64% | 1 |
|
|
2022
Q3 | $168M | Sell |
1,976,265
-85,108
| -4% | -$7.21M | 13.25% | 1 |
|
|
2022
Q2 | $171M | Sell |
2,061,373
-78,241
| -4% | -$6.48M | 14.89% | 1 |
|
|
2022
Q1 | $165M | Sell |
2,139,614
-73,336
| -3% | -$5.65M | 12.75% | 1 |
|
|
2021
Q4 | $196M | Hold |
2,212,950
| – | – | 12.49% | 1 |
|
|
2021
Q3 | $171M | Hold |
2,212,950
| – | – | 10.32% | 2 |
|
|
2021
Q2 | $185M | Buy |
2,212,950
+7,200
| +0.3% | +$601K | 10.18% | 2 |
|
|
2021
Q1 | $167M | Buy |
2,205,750
+50,700
| +2% | +$3.83M | 9.49% | 4 |
|
|
2020
Q4 | $189M | Buy |
2,155,050
+422,500
| +24% | +$37M | 9.91% | 3 |
|
|
2020
Q3 | $132M | Buy |
1,732,550
+326,600
| +23% | +$24.8M | 7.23% | 5 |
|
|
2020
Q2 | $173M | Sell |
1,405,950
-138,213
| -9% | -$17M | 10.41% | 3 |
|
|
2020
Q1 | $130M | Sell |
1,544,163
-476,973
| -24% | -$40.3M | 10.93% | 1 |
|
|
2019
Q4 | $171M | Sell |
2,021,136
-188,368
| -9% | -$15.9M | 9.41% | 1 |
|
|
2019
Q3 | $149M | Sell |
2,209,504
-396,981
| -15% | -$26.8M | 9.92% | 1 |
|
|
2019
Q2 | $223M | Sell |
2,606,485
-35,000
| -1% | -$3M | 10.85% | 1 |
|
|
2019
Q1 | $235M | Buy |
2,641,485
+81,752
| +3% | +$7.26M | 9.79% | 1 |
|
|
2018
Q4 | $218M | Buy |
2,559,733
+10,302
| +0.4% | +$877K | 11.6% | 2 |
|
|
2018
Q3 | $247M | Hold |
2,549,431
| – | – | 9.99% | 2 |
|
|
2018
Q2 | $240M | Buy |
2,549,431
+3,949
| +0.2% | +$372K | 9.6% | 2 |
|
|
2018
Q1 | $206M | Buy |
2,545,482
+47,676
| +2% | +$3.87M | 8.82% | 3 |
|
|
2017
Q4 | $223M | Buy |
2,497,806
+59,287
| +2% | +$5.29M | 9.59% | 4 |
|
|
2017
Q3 | $227M | Buy |
2,438,519
+53,800
| +2% | +$5.01M | 9.56% | 3 |
|
|
2017
Q2 | $217M | Buy |
2,384,719
+2,100
| +0.1% | +$191K | 10.11% | 4 |
|
|
2017
Q1 | $209M | Buy |
2,382,619
+422,400
| +22% | +$37.1M | 9.89% | 4 |
|
|
2016
Q4 | $162M | Buy |
1,960,219
+169,320
| +9% | +$14M | 9.26% | 4 |
|
|
2016
Q3 | $166M | Buy |
1,790,899
+53,500
| +3% | +$4.95M | 9.62% | 3 |
|
|
2016
Q2 | $135M | Buy |
1,737,399
+397,052
| +30% | +$30.9M | 10.21% | 3 |
|
|
2016
Q1 | $111M | Buy |
1,340,347
+3,500
| +0.3% | +$289K | 8.58% | 4 |
|
|
2015
Q4 | $140M | Sell |
1,336,847
-329,645
| -20% | -$34.5M | 7.79% | 4 |
|
|
2015
Q3 | $176M | Buy |
1,666,492
+6,400
| +0.4% | +$674K | 8.44% | 5 |
|
|
2015
Q2 | $227M | Buy |
1,660,092
+10,300
| +0.6% | +$1.41M | 10.1% | 3 |
|
|
2015
Q1 | $206M | Buy |
1,649,792
+347,595
| +27% | +$43.3M | 10.16% | 2 |
|
|
2014
Q4 | $118M | Buy |
1,302,197
+37,800
| +3% | +$3.42M | 6.91% | 5 |
|
|
2014
Q3 | $91.2M | Buy |
1,264,397
+348,810
| +38% | +$25.2M | 6.82% | 4 |
|
|
2014
Q2 | $57M | Buy |
915,587
+169,900
| +23% | +$10.6M | 4.24% | 6 |
|
|
2014
Q1 | $50.9M | Buy |
745,687
+4,600
| +0.6% | +$314K | 4.2% | 9 |
|
|
2013
Q4 | $52.1M | Buy |
741,087
+176,800
| +31% | +$12.4M | 4.86% | 8 |
|
|
2013
Q3 | $40.7M | Sell |
564,287
-222,832
| -28% | -$16.1M | 4.27% | 10 |
|
|
2013
Q2 | $43.9M | Buy |
+787,119
| New | +$43.9M | 5.18% | 7 |
|